| Title |
Scalable Manufacturing of CAR T Cells for Cancer ImmunotherapyClinical Production of CAR T Cells
|
|---|---|
| Published in |
Blood Cancer Discovery, August 2021
|
| DOI | 10.1158/2643-3230.bcd-21-0084 |
| Pubmed ID | |
| Authors |
Mohamed Abou-el-Enein, Magdi Elsallab, Steven A. Feldman, Andrew D. Fesnak, Helen E. Heslop, Peter Marks, Brian G. Till, Gerhard Bauer, Barbara Savoldo |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 35% |
| Colombia | 1 | 4% |
| Germany | 1 | 4% |
| Spain | 1 | 4% |
| Comoros | 1 | 4% |
| United Kingdom | 1 | 4% |
| Hong Kong | 1 | 4% |
| Russia | 1 | 4% |
| Unknown | 8 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 61% |
| Scientists | 5 | 22% |
| Practitioners (doctors, other healthcare professionals) | 2 | 9% |
| Science communicators (journalists, bloggers, editors) | 2 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 228 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 228 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 34 | 15% |
| Student > Ph. D. Student | 26 | 11% |
| Student > Bachelor | 19 | 8% |
| Student > Master | 10 | 4% |
| Student > Doctoral Student | 9 | 4% |
| Other | 31 | 14% |
| Unknown | 99 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 33 | 14% |
| Immunology and Microbiology | 18 | 8% |
| Engineering | 16 | 7% |
| Chemical Engineering | 13 | 6% |
| Medicine and Dentistry | 12 | 5% |
| Other | 33 | 14% |
| Unknown | 103 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2024.
All research outputs
#1,550,526
of 25,605,018 outputs
Outputs from Blood Cancer Discovery
#66
of 211 outputs
Outputs of similar age
#36,794
of 439,868 outputs
Outputs of similar age from Blood Cancer Discovery
#11
of 21 outputs
Altmetric has tracked 25,605,018 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 211 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,868 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.